Literature DB >> 35441316

Orbital myositis in systemic lupus erythematosus: a case-based review.

Voulgari V Paraskevi1, Venetsanopoulou I Aliki2, Pieta Antigone2, Tziortzioti Zoi2, Zikou K Anastasia3, Drosos A Alexandros2.   

Abstract

Ocular complications occur in up to one-third of patients with systemic lupus erythematosus (SLE). Among them, orbital myositis (OM) is considered a rare manifestation that affects the extraocular muscles and causes pain and restriction with eye movement. We report a case of OM in a 48-year-old female with SLE and secondary Sjogren's Syndrome, who presented headache, periorbital edema, and painful ocular movements in both eyes, with no other systemic manifestations. An orbital magnetic resonance image revealed thickening of the right medial rectus and left lateral rectus muscles. Laboratory tests were normal and there was no further disease activity. The patient was treated with prednisone 1 mg/Kg/day with a resolution of symptoms. We found 13 additional cases of OM from our literature review (11 SLE patients and 2 with discoid lupus erythematosus). There was a female predominance in these cases with a mean age of 43.6 years (SD ± 16.9). Their main clinical features included eye pain, swelling, proptosis, diplopia, and limitations in extraocular muscles, while in most of them, there was no other active systemic manifestation. Treatment with steroids led to the complete resolution of symptoms in most of these patients. The available evidence suggests that it is essential to have a high index of suspicion for OM in SLE patients even when there is no systemic disease activity so that proper treatment is initiated early.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Orbital myositis; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2022        PMID: 35441316     DOI: 10.1007/s00296-022-05114-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  39 in total

1.  Acute ocular ischaemia and orbital inflammation associated with systemic lupus erythematosus.

Authors:  P Stavrou; P I Murray; K Batta; C Gordon
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

Review 2.  Ocular manifestations in systemic lupus erythematosus.

Authors:  Sukhum Silpa-archa; Joan J Lee; C Stephen Foster
Journal:  Br J Ophthalmol       Date:  2015-04-22       Impact factor: 4.638

Review 3.  Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis.

Authors:  D Giorgi; C Balacco Gabrieli
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

Review 4.  Orbital Myositis: A Comprehensive Review and Reclassification.

Authors:  Alan A McNab
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2020 Mar/Apr       Impact factor: 1.746

Review 5.  Demyelination in rheumatic diseases.

Authors:  A Theodoridou; L Settas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

6.  CT imaging of head and neck lupus panniculitis.

Authors:  S Vattoth; J K Curé
Journal:  AJNR Am J Neuroradiol       Date:  2008-11-27       Impact factor: 3.825

7.  Optic neuropathy in systemic lupus erythematosus.

Authors:  D A Jabs; N R Miller; S A Newman; M A Johnson; M B Stevens
Journal:  Arch Ophthalmol       Date:  1986-04

Review 8.  Systemic lupus erythematosus and ocular involvement: an overview.

Authors:  Rosanna Dammacco
Journal:  Clin Exp Med       Date:  2017-12-14       Impact factor: 3.984

9.  Ocular manifestations of systemic lupus erythematosus: a review of the literature.

Authors:  Neal V Palejwala; Harpreet S Walia; Steven Yeh
Journal:  Autoimmune Dis       Date:  2012-07-02

Review 10.  Ocular findings in systemic lupus erythematosus.

Authors:  Samir S Shoughy; Khalid F Tabbara
Journal:  Saudi J Ophthalmol       Date:  2016-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.